Meta-analysis of cerebrospinal fluid neuron-specific enolase levels in Alzheimer’s disease, Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy

BACKGROUND: This study examined the usefulness of cerebrospinal fluid (CSF) neuron-specific enolase (NSE) levels as a candidate biomarker of neurodegeneration in Alzheimer’s disease (AD), Parkinson’s disease (PD), PD with dementia (PDD), dementia with Lewy bodies (DLB), and multiple system atrophy (...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Takayuki, Sawada, Jun, Takahashi, Kae, Yahara, Osamu, Hasebe, Naoyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493707/
https://www.ncbi.nlm.nih.gov/pubmed/34610837
http://dx.doi.org/10.1186/s13195-021-00907-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8493707/
https://www.ncbi.nlm.nih.gov/pubmed/34610837
http://dx.doi.org/10.1186/s13195-021-00907-3

Ejemplares similares